This is a prospective, single-center, single-arm Phase II study evaluating the efficacy of the myDIET software tool in the nutritional management of patients with localized and resectable esogastric junction cancer.
Patient 18 years of age or older at date of signing informed consent to participate;
Histologically proven diagnosis of gastric adenocarcinoma or OGJ;
Localized, resectable disease;
Patients with an indication for perioperative chemotherapy and/or immunotherapy validated in multidisciplinary consultation meeting, with a scheduled surgery date at least 1 month after enrolment;
Other associated solid cancer or haemopathy;
Presence of severe comorbidity (Charlson index > 9)
Presence of unbalanced dysthyroidism;
History of gastric, duodenal or esophageal surgery;